The PRECISEU Best Practice Recognition 2025 is more than a contest—it is a movement to accelerate the future of personalised medicine across Europe. Born from the PeRsonalised medicine Empowerment Connecting Innovation ecoSystems across EUrope (PRECISEU) programme, this visionary initiative shines a spotlight on pioneers who are translating cutting-edge science into real-world care—especially through the innovative and responsible use of health data.
With ambitious purpose it celebrates exemplary practices that not only push the boundaries of what’s possible but also make these breakthroughs accessible, equitable, and impactful for all. This recognition is a catalyst for transformation—bridging science and society, innovation and implementation, vision and care. It calls upon researchers, entrepreneurs, institutions, and citizens alike to lead with purpose, collaborate boldly, and ensure that life-changing therapies reach every patient, everywhere—fast and fair.
PRECISEU Best Practice Recognition honours not just innovation, but the courage to act, the will to include, and the power to change lives.
Let’s celebrate the winners of our first edition: PRECISEU Best Practice Recognition 2025 !
Recognition Categories
The initiative acknowledges excellence in four distinct categories:
IMPACT Celebrating academic-business partnerships that have led to significant healthcare improvements
INNOVATION Recognizing SMEs and startups revolutionizing patient care with advanced therapies
EXCELLENCE Acknowledging leaders in health data accessibility, security, and inclusivity
CULTURE Honoring organizations that excel in patient engagement and public outreach.
IMPACT – From Insight to Intervention
This category rewards dynamic partnerships between research institutions and industry that have successfully translated scientific discovery into practical, real-world health solutions. It honours those who not only invent but also implement — demonstrating measurable improvements in care delivery and patient outcomes.
WINNER: DIPCAN
Miquel A. Bru (Genomcore, S.L.)
DIPCAN, powered by GENOMCORE BIMS, accelerates Europe’s ATMP innovation by enabling EHDS-compliant federated data sharing, advanced multimodal AI analytics, and ensuring regulatory trust, driving faster personalized clinical breakthroughs.
JURY STATEMENTS “DIPCAN is a project of outstanding quality across nearly all evaluation areas”; ”The DIPCAN project effectively illustrates the translation of a sophisticated data infrastructure into measurable clinical and research outcomes at a national level.”
INNOVATION – Pushing the Boundaries of What’s Possible
Designed for SMEs, startups, and spin-offs, this category celebrates those on the cutting edge of health innovation. It shines a light on emerging technologies, advanced therapies, and disruptive solutions that are redefining the landscape of personalised care—offering hope where standard treatments fall short.
WINNER: OPORA Health
Daria Volkova, Svitlana Surodina and Yegor Cotov (OPORA Health)
OPORA Health is an AI-ready platform for secure, multimodal brain health data, supporting PTSD care and research in war-affected populations across Ukraine, the UK, and Europe.
JURY STATEMENTS “very relevant unmet health need”; ” this project is excellent [..] because it comprehensively matches all criteria of the call”
EXCELLENCE – Harnessing the Power of Data
At the heart of personalised medicine lies data. This category honours outstanding achievements in data accessibility, interoperability, privacy, and ethical use. It recognises initiatives that unlock the full potential of health data to support decision-making, advance research, and drive fair, future-ready health systems.
WINNER: PragmaTIL
Silvia Martín Lluesma, Elena Garralda, Alena Gros (Vall d’Hebron Institute of Oncology-VHIO) and Inés Vaz-Luis (Goustave Roussy)
The PragmaTIL trial aims to optimize TIL-ACT for cancer and enhance its clinical use in academic hospitals.
JURY STATEMENTS “[PragmaTIL] has an original concept of decentralized patient care with ATMPs leading to great sustainability”; ”innovative approach to decentralize manufacturing across different countries within a clinical trial”
the PragmaTIL Team
CULTURE – Building Trust and Engagement
True transformation begins with people. This category acknowledges initiatives that promote a culture of inclusion, education, and empowerment in healthcare. By fostering patient engagement, raising public awareness, and enhancing health literacy, these projects ensure that innovation is not only advanced—but embraced.
WINNER: ENGAGE ATMP
Alessandra Magnani (Fundació Privada Recerca i Docència Sant Joan de Déu, FSJD-CERCA), Joan Vinyets Rejon (Hospital Sant Joan de Déu, HSJD), Begonya Nafria Escalera (FSJD-CERCA).
ENGAGE-ATMP is an innovative, patient-centric translational model for ATMP research and healthcare, to provide holistic, accessible care while empowering patients and caregivers to actively participate in the process.
JURY STATEMENTS “Excellent patient-centering methods and perspective”; ”[ENGAGE-ATMP] represents a benchmark in cultural transformation around patient engagement in ATMP research and care. Its long-standing, institutionalized approach demonstrates maturity, inclusivity, and real-world impact, particularly in pediatric rare disease contexts.”
Joan Vinyets Rejon, Alessandra Magnani and Simón De Miquel
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.